Read the latest insights and analysis on small-cap investing, CEO interviews, and market trends.
A groundbreaking biotech firm's lifesaving research was nearly derailed by corporate turmoil until Creatd stepped in, transforming Enzolytics from a troubled company into a potential powerhouse in the fight against HIV, cancer, and immune disorders through innovative antibody therapies and AI-driven drug discovery.
CEOBLOC
February 3, 2025
Creatd Takes Flight with Flewber Acquisition, Driving Growth and Shareholder Value
CEOBLOC
February 3, 2025
The Case for Buying into Leadership and Betting on the Jockey at Geopulse Exploration (OTC: GPLS)
CEOBLOC
January 16, 2025
Entrepreneurs and small business owners are the lifeblood of innovation and economic growth. Yet, in times of financial strain, they often find themselves prey to unscrupulous financiers who exploit their vulnerability for profit. One such financier, Detroit-based Jack Bodenstein of Coventry Enterprises LLC, has built a reputation as a predatory lender in the small-cap and microcap investment world. This investigative report uncovers the toxic practices of Bodenstein and his firm, shedding light on their devastating impact on struggling businesses.
CEOBLOC
January 7, 2025
The Case for Undervalued Music Assets at Hollywall Entertainment’s (OTC: HWAL)
CEOBLOC
January 2, 2025
Understand the stock market hierarchy, from NASDAQ and NYSE to OTC and Expert Markets. Learn the benefits, risks, and implications for investors and companies.
CEOBLOC
December 30, 2024
As we approach the end of the summer, which has been one of the most challenging periods of my career, there is no time to rest.
CEOBLOC
November 11, 2024
As we approach the end of the summer, which has been one of the most challenging periods of my career, there is no time to rest.
CEOBLOC
August 29, 2024
Every day, I encounter skepticism about the future of the OTC market, particularly for micro and nano-cap stocks.
CEOBLOC
August 10, 2024